Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| BIAF | 8-K | bullish | 5/10 | bioAffinity Technologies reported that sales of its CyPath Lung test more than doubled year-over-year through Q3 2026, w | Oct 6, 2026 |
| AUUD | 8-K | bearish | 6/10 | Auddia canceled its October 7 special shareholder meeting to vote on the merger with Thramann Holdings because, despite | Oct 6, 2026 |
| RTB | 8-K | neutral | 4/10 | RTB Digital appointed Erin Schaefer as a director on October 1, 2026. Ms. Schaefer brings extensive experience from Goog | Oct 6, 2026 |
| OPCH | 8-K | bullish | 7/10 | Option Care Health has entered into a definitive agreement to be acquired by an investor group led by CD&R (majority own | Oct 6, 2026 |
| ONAR | 8-K | neutral | 4/10 | ONAR appointed Audit Committee Chair Kelly Anderson as Interim CFO effective October 1, 2026, via an interim services ag | Oct 6, 2026 |
| HUBS | 8-K | mixed | 6/10 | HubSpot announced a restructuring plan to eliminate ~7% of its workforce (~660 employees), incurring $65M-$75M in charge | Oct 6, 2026 |
| MAIA | 8-K | neutral | 2/10 | MAIA Biotechnology filed an 8-K furnishing a corporate presentation and summary under Regulation FD, posted to its websi | Oct 6, 2026 |
| SYK | 8-K | neutral | 3/10 | Stryker announced a planned CEO succession: Kevin Lobo will transition to Executive Chair effective January 1, 2027, and | Oct 6, 2026 |
| IBOC | 8-K | neutral | 4/10 | International Bancshares Corporation (IBOC) is voluntarily delisting its common stock from Nasdaq and transferring its p | Oct 6, 2026 |
| AVBP | 8-K | bearish | 7/10 | ArriVent announced that its Phase 3 FURVENT trial of firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC did | Oct 6, 2026 |
| PDSB | 8-K | neutral | 3/10 | PDS Biotechnology filed an 8-K announcing a virtual KOL event on October 15, 2026, to discuss Phase 2 clinical outcomes | Oct 6, 2026 |
| NLST | 8-K | bullish | 8/10 | Netlist settled all litigation with Micron and granted a 5-year patent license for $30M/quarter ($600M total). Micron al | Oct 6, 2026 |
| MCK | 8-K | bullish | 6/10 | McKesson, alongside private equity firm CDR, has entered into a definitive agreement to acquire Option Care Health (OPCH | Oct 6, 2026 |
| LW | 8-K | bullish | 6/10 | Lamb Weston reported Q1 FY2027 adjusted diluted EPS of $0.75, above the $0.59 consensus estimate, and net sales of $1.67 | Oct 6, 2026 |
| FUL | 8-K | mixed | 6/10 | H.B. Fuller commenced a $950 million private offering of senior unsecured notes due 2034 to fund the acquisition of Adva | Oct 6, 2026 |
| PTLO | 8-K | neutral | 2/10 | Portillo's Inc. disclosed the departure of Chief People Officer Jill Waite, effective November 1, 2026, under a qualifyi | Oct 6, 2026 |
| BGS | 8-K | neutral | 4/10 | B&G Foods and Nortera Foods mutually terminated their asset purchase agreement for the sale of Green Giant Canada after | Oct 6, 2026 |
| CBDW | 8-K | neutral | 3/10 | 1606 Corp. issued a press release updating on its East Texas energy and data center project, reporting that multiple pro | Oct 6, 2026 |
| TELO | 8-K | neutral | 5/10 | Telomir Pharmaceuticals closed a ~$5.6M PIPE financing on October 5, 2026, issuing 4,843,300 common shares at $1.16/shar | Oct 6, 2026 |
| BRUN | 8-K | bullish | 6/10 | Boost Run Inc.'s subsidiary, Boost Run LLC, entered into a five-year GPU cloud infrastructure service agreement with Coh | Oct 6, 2026 |
| ENTX | 8-K | neutral | 3/10 | Entera Bio appointed former Gilead and Amgen executive Laura Hamill to its Board of Directors, effective December 1, 202 | Oct 6, 2026 |
| OFS | 8-K | bullish | 5/10 | OFS Capital admitted a third-party investor to its SBIC I LP subsidiary, which holds a concentrated stake in Pfanstiehl | Oct 6, 2026 |
| EMAT | 8-K | bullish | 6/10 | Evolution Metals & Technologies (EMAT) signed a non-binding Letter of Intent with UK-based INERGX Energy Optimisation Lt | Oct 6, 2026 |
| REGN | 8-K | bullish | 7/10 | Regeneron and Sanofi expanded their antibody collaboration via the Sixth Amendment, with Sanofi paying a $1.0B upfront a | Oct 6, 2026 |
| SXTP | 8-K | neutral | 5/10 | 60 Degrees Pharmaceuticals announced it will conclude enrollment in its randomized severe babesiosis study at 30 patient | Oct 6, 2026 |
| VBIO | 8-K | neutral | 2/10 | Valion Bio issued a press release highlighting the expertise of new Board Chair Thomas Jensen, who brings biotech turnar | Oct 6, 2026 |
| KAPA | 8-K | bullish | 6/10 | Kairos Pharma reported positive interim Phase 2 data for ENV-105 (carotuximab) in metastatic castration-resistant prosta | Oct 6, 2026 |
| IPDN | 8-K | mixed | 5/10 | Professional Diversity Network, through its subsidiary PDN Intelligence, entered into agreements to deploy two NVIDIA B3 | Oct 6, 2026 |
| INDV | 8-K | neutral | 3/10 | Indivior filed an 8-K supplementing its joint proxy statement/prospectus for the pending merger with Supernus, adding su | Oct 6, 2026 |
| BLNE | 8-K | bullish | 6/10 | Beeline Holdings issued a press release providing preliminary Q3 2026 guidance: revenue expected to be the second-highes | Oct 6, 2026 |